8-K: Jaguar Health Extends Lucid Capital ATM Role
Amendment to Offering Agreement
Jaguar Health, Inc. amended its At-the-Market Offering Agreement to extend Lucid Capital Markets' role as a manager until December 31, 2025.
Summary
- Jaguar Health, Inc. (the Company) entered into the Sixth ATM Amendment to its At the Market Offering Agreement (the Agreement) on August 14, 2025.
- The amendment extends the term for Lucid Capital Markets, LLC (Lucid) to continue serving as a Manager under the Agreement retrospectively from June 30, 2025, to December 31, 2025.
- If not further extended, Ladenburg Thalmann & Co. Inc. (Ladenburg) will become the sole Manager after December 31, 2025, and Lucid will no longer serve in that capacity.
- The Company filed a prospectus supplement with the SEC on August 14, 2025, related to this Sixth ATM Amendment.
- Jaguar Health, Inc. will reimburse Ladenburg's counsel for fees and expenses up to $2,500 related to this amendment and due diligence.
Sentiment
Score: 5
Explanation: The filing is an administrative update to an existing financing agreement, extending the term of a manager. It does not contain new financial results, strategic shifts, or significant positive/negative news that would alter the company's fundamental outlook.
Positives
- NA
Negatives
- The Company incurred a minor expense of up to $2,500 for Ladenburg's counsel fees related to the amendment.
Risks
- NA
Future Outlook
Lucid Capital Markets, LLC's term as a Manager under the At the Market Offering Agreement is extended until December 31, 2025, unless further extended. If not extended, Ladenburg Thalmann & Co. Inc. will become the sole Manager after this date.
Industry Context
At-the-Market (ATM) offering agreements are common financing tools for publicly traded companies, particularly in sectors like biotechnology, allowing them to raise capital flexibly by selling shares directly into the market at prevailing prices. This amendment is an administrative update to an existing ATM facility.
Stakeholder Impact
- Shareholders may experience potential dilution if the company issues new shares under the ATM agreement, although this filing is an amendment to the agreement, not an announcement of share issuance.
Next Steps
- Lucid Capital Markets, LLC will continue to serve as a Manager under the ATM Agreement until December 31, 2025, unless further extended.
- If not further amended or extended, Ladenburg Thalmann & Co. Inc. will become the sole Manager after December 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 2021-12-10 | Original At The Market Offering Agreement date. |
| 2022-02-02 | Date of first amendment to the ATM Agreement. |
| 2024-05-01 | Date of accompanying prospectus related to the ATM Agreement. |
| 2024-05-23 | Date of prospectus supplement and third amendment to the ATM Agreement. |
| 2024-07-17 | Date of fourth amendment to the ATM Agreement. |
| 2024-11-13 | Date of fifth amendment to the ATM Agreement. |
| 2025-02-04 | Date of sixth amendment to the ATM Agreement. |
| 2025-06-30 | Original retrospective end date for Lucid Capital Markets' term as Manager. |
| 2025-08-14 | Date of the Sixth ATM Amendment and filing of the prospectus supplement and 8-K report. |
| 2025-12-31 | New extended term end date for Lucid Capital Markets, LLC as a Manager under the ATM Agreement. |
Keywords
Jaguar Health, JAGX, ATM Offering, Equity Financing, Capital Markets, SEC Filing, 8-K, Ladenburg Thalmann, Lucid Capital Markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.